722 reports of this reaction
1.5% of all MINOCYCLINE HYDROCHLORIDE reports
#10 most reported adverse reaction
FATIGUE is the #10 most commonly reported adverse reaction for MINOCYCLINE HYDROCHLORIDE, manufactured by Melinta Therapeutics, LLC. There are 722 FDA adverse event reports linking MINOCYCLINE HYDROCHLORIDE to FATIGUE. This represents approximately 1.5% of all 49,345 adverse event reports for this drug.
Patients taking MINOCYCLINE HYDROCHLORIDE who experience fatigue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FATIGUE is a less commonly reported adverse event for MINOCYCLINE HYDROCHLORIDE, but still significant enough to appear in the safety profile.
In addition to fatigue, the following adverse reactions have been reported for MINOCYCLINE HYDROCHLORIDE:
The following drugs have also been linked to fatigue in FDA adverse event reports:
FATIGUE has been reported as an adverse event in 722 FDA reports for MINOCYCLINE HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
FATIGUE accounts for approximately 1.5% of all adverse event reports for MINOCYCLINE HYDROCHLORIDE, making it a notable side effect.
If you experience fatigue while taking MINOCYCLINE HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.